AGT and triple-A syndrome: Besides, another study has found that pretreatment of elderly mice with oral anti-aging agents (dasatinib + quercetin) can reduce the abundance of senescent cells in the arterial wall and surrounding tissues, and inhibit the severity of Ang II-induced AAA (99).